Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis
Status:
Unknown status
Trial end date:
2021-08-31
Target enrollment:
Participant gender:
Summary
A randomized, placebo-controlled, double-blinded cross-over study evaluating and quantifying
the effect of pyridostigmine on muscle strength and symptoms in Myasthenia Gravis (MG)